Akanda (AKAN) Long-Term Investments (2020 - 2025)
Akanda's (AKAN) quarterly Long-Term Investments came in at $504136.0 in Q4 2025, up 36.06% year-on-year from $370537.0 in Q4 2024, and up 36.06% quarter-over-quarter from $370537.0 in Q4 2024.
Akanda (AKAN) Long-Term Investments (2020 - 2025) Analysis & Trends
Akanda's Long-Term Investments history runs 6 years deep, the most recent figure standing at $504136.0 for Q4 2025.
- On a quarterly basis, Long-Term Investments rose 36.06% year-over-year to $504136.0 in Q4 2025; TTM through Dec 2025 was $504136.0, a 36.06% increase from a year earlier, with the FY2025 full-year figure at $504136.0, up 36.06% from the prior year.
- Long-Term Investments grew to $504136.0 in Q4 2025 per AKAN's latest filing, from $370537.0 in the prior quarter.
- Across five years, Long-Term Investments topped out at $504136.0 in Q4 2025 and bottomed at $93875.0 in Q4 2023.
- The 5-year median for Long-Term Investments is $255803.0 (2022), against an average of $293341.6.
- Across the five-year window, Long-Term Investments jumped 1694.71% in 2021 and slumped 63.3% in 2023, its largest moves.
- Year by year, Long-Term Investments stood at $242357.0 in 2021, then gained by 5.55% to $255803.0 in 2022, then slumped by 63.3% to $93875.0 in 2023, then surged by 294.71% to $370537.0 in 2024, then jumped by 36.06% to $504136.0 in 2025.
- Per Business Quant, the three latest AKAN Long-Term Investments figures stand at $504136.0 (Q4 2025), $370537.0 (Q4 2024), and $93875.0 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Akanda | 556,353.85 | 556,353.85 | - | 504,136.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 504,136.00 |
| Dec 31, 2024 | 370,537.00 |
| Dec 31, 2023 | 93,875.00 |
| Dec 31, 2022 | 255,803.00 |
| Dec 31, 2021 | 242,357.00 |
| Dec 31, 2020 | 13,504.00 |